Molecular Devices, Arcturus, Sanger Institute, Caliper, Zygogen, DanioLabs, Fox Chase Cancer Center, Dharmacon, Sigma-Aldrich, LI-COR | GenomeWeb

Molecular Devices Buys Arcturus' Laser Capture Microdissection Business for $10M

Molecular Devices has acquired the laser capture microdissection business of Arcturus Biosicence for $10 million in cash, the company said this week.

Under the terms of the agreement, Molecular Devices acquired Arcturus' LCM-related assets and hired 42 Arcturus employees. LCM operations will immediately move to Molecular Devices' headquarters in Sunnyvale, Calif. The company expects that the acquisition will increase its revenues by $8 million to $10 million this year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.